Cargando…
Emerging targets in cancer management: role of the CXCL12/CXCR4 axis
The chemokine CXCL12 (SDF-1) and its cell surface receptor CXCR4 were first identified as regulators of lymphocyte trafficking to the bone marrow. Soon after, the CXCL12/CXCR4 axis was proposed to regulate the trafficking of breast cancer cells to sites of metastasis. More recently, it was establish...
Autores principales: | Cojoc, Monica, Peitzsch, Claudia, Trautmann, Franziska, Polishchuk, Leo, Telegeev, Gennady D, Dubrovska, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794844/ https://www.ncbi.nlm.nih.gov/pubmed/24124379 http://dx.doi.org/10.2147/OTT.S36109 |
Ejemplares similares
-
CXCR4/CXCR7/CXCL12-Axis in Follicular Thyroid Carcinoma
por: Werner, Thomas Artur, et al.
Publicado: (2018) -
The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer
por: Shi, Yi, et al.
Publicado: (2020) -
The controversial role of phospholipase C epsilon (PLCε) in cancer development and progression
por: Tyutyunnykova, Anna, et al.
Publicado: (2017) -
CXCL12-CXCR4 axis in feline mammary carcinoma
por: Ferreira, Fernando
Publicado: (2017) -
CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies
por: Khare, Tripti, et al.
Publicado: (2021)